Biotherapeutics
Drug development research is continuing to shift to targeted protein therapeutic drugs and there is a critical need for disruptive technologies that provide rapid and consistent results throughout the protein workflow.
PerkinElmer is dedicated to helping a global user community of researchers and manufacturers accelerate the assessment, development and production of biotherapeutics, vaccines and biosimilars in a validated environment.
Our reagents, detection technologies, imaging systems, sample preparation workstations, informatics platforms and training courses provide scientists with consistent protein characterization, improved workflow efficiencies and critical tracking of life saving medicines.